| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0126064AGB0126064D0 (en) | 2001-10-30 | 2001-10-30 | Improvements in or relating to organic compositions |
| EP02774957AEP1441745A1 (en) | 2001-10-30 | 2002-10-30 | Polyacrylate compositions for use in protecting mucosa |
| PCT/GB2002/004906WO2003037355A1 (en) | 2001-10-30 | 2002-10-30 | Polyacrylate compositions for use in protecting mucosa |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0126064AGB0126064D0 (en) | 2001-10-30 | 2001-10-30 | Improvements in or relating to organic compositions |
| Publication Number | Publication Date |
|---|---|
| GB0126064D0true GB0126064D0 (en) | 2001-12-19 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0126064ACeasedGB0126064D0 (en) | 2001-10-30 | 2001-10-30 | Improvements in or relating to organic compositions |
| Country | Link |
|---|---|
| EP (1) | EP1441745A1 (en) |
| GB (1) | GB0126064D0 (en) |
| WO (1) | WO2003037355A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2537080A1 (en)* | 2003-08-21 | 2005-03-31 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| MX336789B (en)* | 2007-08-13 | 2016-02-02 | Inspirion Delivery Technologies Llc | Abuse resistant drugs, method of use and method of making. |
| US9220759B2 (en) | 2012-02-23 | 2015-12-29 | Abbott Cardiovascular Systems Inc. | Treatment of diabetic patients with a drug eluting stent and adjunctive therapy |
| US9220584B2 (en) | 2012-03-30 | 2015-12-29 | Abbott Cardiovascular Systems Inc. | Treatment of diabetic patients with a stent and locally administered adjunctive therapy |
| US9789071B2 (en) | 2012-06-27 | 2017-10-17 | G2B Pharma, Inc. | Intranasal formulation of epinephrine for the treatment of anaphylaxis |
| ES2774978T3 (en) | 2014-08-11 | 2020-07-23 | Perora Gmbh | Formulation comprising particles |
| RU2690672C2 (en) | 2014-08-11 | 2019-06-05 | Перора Гмбх | Method of inducing satiety |
| WO2017005890A1 (en) | 2015-07-07 | 2017-01-12 | Perora Gmbh | Method of inducing satiety |
| CA2989508A1 (en) | 2015-07-07 | 2017-01-12 | Perora Gmbh | Formulation comprising particles and a lipase inhibitor |
| US12414916B2 (en) | 2021-06-10 | 2025-09-16 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
| US11617716B2 (en) | 2021-06-10 | 2023-04-04 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
| US12005185B2 (en) | 2021-12-17 | 2024-06-11 | Belhaven BioPharma Inc. | Medical counter measures including dry powder formulations and associated methods |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5138412A (en)* | 1974-09-24 | 1976-03-31 | Nippon Kayaku Kk | Kokoseizai no seiho |
| GB8419245D0 (en)* | 1984-07-27 | 1984-08-30 | Reckitt & Colmann Prod Ltd | Medicinal compositions |
| NZ215069A (en)* | 1985-03-01 | 1988-06-30 | Reckitt & Colmann Prod Ltd | Pharmaceutical composition with histamine h 2 -receptor antagonist |
| US5324746A (en)* | 1993-02-12 | 1994-06-28 | Mckee Rex N | Method of treating damaged mucosal and epithelial tissues with misoprostol |
| IT1273742B (en)* | 1994-08-01 | 1997-07-09 | Lifegroup Spa | HIGH BIO ADHESIVE AND MUCO ADHESIVE COMPOSITIONS USEFUL FOR THE TREATMENT OF EPITALS AND MUCOSES |
| US6239119B1 (en)* | 1998-04-27 | 2001-05-29 | Medimmune Oncology, Inc. | Topical administration of amifostine and related compounds |
| US7547433B2 (en)* | 2001-02-15 | 2009-06-16 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| Publication number | Publication date |
|---|---|
| WO2003037355A1 (en) | 2003-05-08 |
| EP1441745A1 (en) | 2004-08-04 |
| Publication | Publication Date | Title |
|---|---|---|
| GB0104153D0 (en) | Improvements in or relating to organic compositions | |
| GB0121111D0 (en) | Improvements in or relating to organic compositions | |
| GB0126347D0 (en) | Improvements in or relating to organic compositions | |
| GB0130419D0 (en) | Improvements in or relating to organic compositions | |
| GB0113854D0 (en) | Improvements in or relating to organic compositions | |
| GB0112779D0 (en) | Improvements in or relating to organic compositions | |
| GB0126064D0 (en) | Improvements in or relating to organic compositions | |
| GB0005840D0 (en) | Improvements in or relating to organic compositions | |
| GB0023898D0 (en) | Improvements in or relating to organic compositions | |
| GB0113052D0 (en) | Improvements in or relating to organic compositions | |
| GB0001879D0 (en) | Improvements in or relating to organic compositions | |
| GB0004769D0 (en) | Improvements in or relating to organic compositions | |
| GB0111836D0 (en) | Improvements in or relating to organic compositions | |
| GB0106876D0 (en) | Improvements in or relating to organic compositions | |
| GB0112774D0 (en) | Improvements in or relating to organic compositions | |
| GB0111112D0 (en) | Improvements in or relating to organic compositions | |
| GB0113401D0 (en) | Improvements in or relating to organic compositions | |
| GB0113405D0 (en) | Improvements in or relating to organic compositions | |
| GB0113482D0 (en) | Improvements in or relating to organic compositions | |
| GB0110102D0 (en) | Improvements in or relating to organic compositions | |
| GB0109584D0 (en) | Improvements in or relating to organic compositions | |
| GB0125348D0 (en) | Improvements in or relating to organic compositions | |
| GB0106879D0 (en) | Improvements in or relating to organic compositions | |
| GB0106849D0 (en) | Improvements in or relating to organic compositions | |
| GB0130178D0 (en) | Improvements in or relating to organic compositions |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |